Skip to main content
. 2012 Oct 5;6:104–112. doi: 10.2174/1874205X01206010104

Table 5b.

Borrelia-LTT Follow-up Studies (Late Manifestations)

Month 0 3 6 9 12
patient 1 12.2 <2* 4.8 <2* 4.2
patient 2 9.4 3.3* <2* 5.8 <2*
patient 3 9.8 4.8* <2* 6.2* 3.9*
patient 4 10.6 5.2* 3.5* <2* 6.4
patient 5 8.5 <2* <2 <2 <2
patient 6 16.2 6.0* 3.2* 7.2 4.8*
patient 7 14.8 <3* <2 4.9 <2*
patient 8 10.8 6.2* 3.8* 8.2 3.6*
patient 9 6.3 <2* <2 <2 <2
patient 10 8.2 <2* <2 5.6 <2*
patient 11 6.6 <2* <2 3.8 3.1*
patient 12 9.1 <3* 4.2 3.6 <2*
patient 13 7.8 4.8 4.2* <3* 3.8
patient 14 6.9 <2* 3.6 <2* 4.9
patient 15 9.6 <2* 5.4 <2* 3.1
patient 16 12.1 4.2 3.1* <2* <2
patient 17 14.4 5.4 4.8* <3* 4.5
patient 18 10.6 <3* <2 <2 <2
*

(4-6 weeks after antibiotic therapy)

Shown are the results of follow-up studies with the Borrelia-LTT over a period of 1 year in 18 patients with late manifestations of borreliosis (an infection more than 2 years previously). Only 3 patients (No. 5, 9 and 10) showed no reactivations after initial treatment with antibiotics.